tesamorelin aod9604 cjc1295 ipamorelin 12mg blend / CJC / Tesamorelin + Ipamorelin (10/3 MG)

AOD9604 and Cardiometabolic Research Because excess adiposity is closely linked to cardiovascular risk, AOD9604 has also been studied in the broader context of cardiometabolic health: Fat reduction alone can influence cardiovascular biomarkers, but some studies suggest that AOD9604 may have effects on metabolic parameters that are not solely explained by weight loss

You start with daily shots for a week

Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Studies on Liver and Metabolic Markers Tesamorelin has been investigated in relation to hepatic lipid accumulation and liver fibrosis progression

Endocrinology, 142(12), 51825189

Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism